Cargando…
Early progression of disease predicts shorter survival in patients with mucosa-associated lymphoid tissue lymphoma receiving systemic treatment
Early progression of disease, within 2 years of diagnosis, is linked with poor overall survival in follicular lymphoma but its prognostic role in extranodal marginal zone B-cell lymphoma is less clear. We sought to identify prognostic factors associated with early progression of disease and to deter...
Autores principales: | Conconi, Annarita, Thieblemont, Catherine, Cascione, Luciano, Torri, Valter, Kiesewetter, Barbara, Casaluci, Gloria Margiotta, Gaidano, Gianluca, Raderer, Markus, Cavalli, Franco, Guillermo, Armando Lopez, Johnson, Peter W., Zucca, Emanuele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604574/ https://www.ncbi.nlm.nih.gov/pubmed/33131248 http://dx.doi.org/10.3324/haematol.2019.237990 |
Ejemplares similares
-
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients
por: Bilgilier, Ceren, et al.
Publicado: (2016) -
Depth of Remission Following First-Line Treatment Is an Independent Prognostic Marker for Progression-Free Survival in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
por: Kiesewetter, Barbara, et al.
Publicado: (2020) -
Prolonged follow‐up on lenalidomide‐based treatment for mucosa‐associated lymphoid tissue lymphoma (MALT lymphoma)—Real‐world data from the Medical University of Vienna
por: Kiesewetter, Barbara, et al.
Publicado: (2019) -
Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma
por: Quéro, Laurent, et al.
Publicado: (2021) -
Clinical Features, Treatment and Outcome of Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Ocular Adnexa: Single Center Experience of 60 Patients
por: Kiesewetter, Barbara, et al.
Publicado: (2014)